AURX
Price
$1.55
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
72.58M
BETRF
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
Jul 21 closing price
Capitalization
9.96M
Interact to see
Advertisement

AURX vs BETRF

Header iconAURX vs BETRF Comparison
Open Charts AURX vs BETRFBanner chart's image
Nuo Therapeutics
Price$1.55
Change-$0.00 (-0.00%)
Volume$20.21K
Capitalization72.58M
BETTERLIFE PHARMA
Price$0.06
Change-$0.01 (-14.29%)
Volume$100
Capitalization9.96M
AURX vs BETRF Comparison Chart in %
Loading...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURX vs. BETRF commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Buy and BETRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (AURX: $1.55 vs. BETRF: $0.06)
Brand notoriety: AURX and BETRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 84% vs. BETRF: 0%
Market capitalization -- AURX: $72.58M vs. BETRF: $9.96M
AURX [@Biotechnology] is valued at $72.58M. BETRF’s [@Biotechnology] market capitalization is $9.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileBETRF’s FA Score has 0 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • BETRF’s FA Score: 0 green, 5 red.
According to our system of comparison, both AURX and BETRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 6 TA indicator(s) are bullish while BETRF’s TA Score has 4 bullish TA indicator(s).

  • AURX’s TA Score: 6 bullish, 4 bearish.
  • BETRF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AURX is a better buy in the short-term than BETRF.

Price Growth

AURX (@Biotechnology) experienced а +10.71% price change this week, while BETRF (@Biotechnology) price change was -5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.81%. For the same industry, the average monthly price growth was +20.92%, and the average quarterly price growth was +30.69%.

Industries' Descriptions

@Biotechnology (+6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURX($72.6M) has a higher market cap than BETRF($9.96M). AURX YTD gains are higher at: 10.714 vs. BETRF (-10.448). BETRF has higher annual earnings (EBITDA): -1.45M vs. AURX (-2.39M). AURX has more cash in the bank: 55.7K vs. BETRF (19K). AURX has less debt than BETRF: AURX (148K) vs BETRF (1.3M). AURX has higher revenues than BETRF: AURX (1.62M) vs BETRF (0).
AURXBETRFAURX / BETRF
Capitalization72.6M9.96M729%
EBITDA-2.39M-1.45M165%
Gain YTD10.714-10.448-103%
P/E RatioN/AN/A-
Revenue1.62M0-
Total Cash55.7K19K293%
Total Debt148K1.3M11%
FUNDAMENTALS RATINGS
AURX vs BETRF: Fundamental Ratings
AURX
BETRF
OUTLOOK RATING
1..100
1831
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3686
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AURX's Valuation (95) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's Profit vs Risk Rating (72) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's SMR Rating (100) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's Price Growth Rating (36) in the null industry is somewhat better than the same rating for BETRF (86). This means that AURX’s stock grew somewhat faster than BETRF’s over the last 12 months.

BETRF's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for AURX (100). This means that BETRF’s stock grew somewhat faster than AURX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AURXBETRF
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 13 days ago
72%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTEGY35.720.34
+0.96%
Deutsche Telekom AG
TNLIY6.81N/A
N/A
Trainline Plc.
EQUEY6.36N/A
N/A
Equatorial Energia S.A.
BBXIA3.54-0.04
-1.12%
BBX Capital, Inc.
LPSIF0.08N/A
-3.07%
Legend Power Systems Inc.

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
27%
Poorly correlated
-1.84%
VRAX - AURX
27%
Poorly correlated
-8.56%
YECO - AURX
26%
Poorly correlated
N/A
QSI - AURX
23%
Poorly correlated
+4.65%
NCNA - AURX
23%
Poorly correlated
+3.92%
More

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and AVCTF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and AVCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
N/A
AVCTF - BETRF
14%
Poorly correlated
N/A
BPMUF - BETRF
6%
Poorly correlated
N/A
BIXT - BETRF
3%
Poorly correlated
-3.61%
AURX - BETRF
-0%
Poorly correlated
N/A
AMGXF - BETRF
-2%
Poorly correlated
N/A
More